Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 3/20 | 0.67 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.67 |
| ▸ | NPBWR1 | P48145 | 5/20 | 0.54 |
| ▸ | ACE | P12821 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | CCKBR | P32239 | 5/20 | 0.49 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30834724 | 0.93 | OPRM1 (0.56) | OPRD1OPRM1ACEKDM4EMEN1 | |
| SCHEMBL29947263 | 0.91 | ACE (0.58) | OPRD1OPRM1ACEKDM4EMEN1 | |
| SCHEMBL30777843 | 0.89 | OPRD1 (0.70) | OPRD1OPRM1NPBWR1ACEKDM4E | |
| Glycine SCHEMBL9868791 | 0.88 | OPRD1 (0.70) | OPRD1OPRM1NPBWR1ACEKDM4E | |
| SCHEMBL5970454 | 0.87 | KDM4E (0.62) | ACEKDM4EMEN1LMNAMPO | |
| SCHEMBL21641798 | 0.87 | KDM4E (0.62) | ACEKDM4EMEN1LMNAMPO | |
| SCHEMBL29493326 | 0.87 | PRMT1 (0.63) | OPRD1OPRM1NPBWR1ACEPRMT1 | |
| SCHEMBL10749608 | 0.86 | OPRD1 (0.68) | OPRD1OPRM1NPBWR1ACEKDM4E | |
| SCHEMBL30169836 | 0.86 | ERAP2 (0.63) | NPBWR1ACE | |
| SCHEMBL30405470 | 0.85 | OPRM1 (0.64) | OPRD1OPRM1NPBWR1ACEKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12257323-B2 | Modified wound dressings | CONVATEC TECHNOLOGIES INC. (US) | 2025-03-25 | — | — | US | disclosed |
| US-20240123091-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES, INC. | 2024-04-18 | — | — | US | disclosed |
| US-11865192-B2 | Modified wound dressings | CONVATEC TECHNOLOGIES, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| EP-3436012-B1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC (US) | 2023-09-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240123091-A1 | MODIFIED WOUND DRESSINGS | MMP8, CD68, ELANE | OPRD1 3705/4885OPRM1 3161/4885NPBWR1 3551/4885 |
| US-11865192-B2 | Modified wound dressings | MMP8, CD68, ELANE | OPRD1 3705/4885OPRM1 3161/4885NPBWR1 3551/4885 |
| US-12257323-B2 | Modified wound dressings | MMP8, CD68, ELANE | OPRD1 3705/4885OPRM1 3161/4885NPBWR1 3551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.